[
  {
    "ts": null,
    "headline": "Abbott Laboratories stock underperforms Monday when compared to competitors",
    "summary": "Abbott Laboratories stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=333ef0bdddce2c2703bed29e8844e36d5c7f3ba7f7b0ff654e260fb504a6be9e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754929980,
      "headline": "Abbott Laboratories stock underperforms Monday when compared to competitors",
      "id": 136331638,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=333ef0bdddce2c2703bed29e8844e36d5c7f3ba7f7b0ff654e260fb504a6be9e"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories shows growth in core products amid market shifts",
    "summary": "Abbott delivered a strong H1 2025, with its US medical device sales growing by 14.8% compared to H1 2024.",
    "url": "https://finnhub.io/api/news?id=95b5058094e05f7a7a8d1fb6ba41df599bc537d3960776f286085a2043a65170",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754928470,
      "headline": "Abbott Laboratories shows growth in core products amid market shifts",
      "id": 136310562,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott delivered a strong H1 2025, with its US medical device sales growing by 14.8% compared to H1 2024.",
      "url": "https://finnhub.io/api/news?id=95b5058094e05f7a7a8d1fb6ba41df599bc537d3960776f286085a2043a65170"
    }
  },
  {
    "ts": null,
    "headline": "SetPoint Medical secures $140M to fund neuromodulation for arthritis",
    "summary": "Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last month.",
    "url": "https://finnhub.io/api/news?id=e4b9b54d81f7ef501f325747d2b967f55766e7786f3980cf66106cee188a72e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754920965,
      "headline": "SetPoint Medical secures $140M to fund neuromodulation for arthritis",
      "id": 136310563,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last month.",
      "url": "https://finnhub.io/api/news?id=e4b9b54d81f7ef501f325747d2b967f55766e7786f3980cf66106cee188a72e4"
    }
  },
  {
    "ts": null,
    "headline": "Are Wall Street Analysts Predicting Abbott Laboratories Stock Will Climb or Sink?",
    "summary": "As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=a81dc5b835cf75033823d9fe1c3beea598b4b22f1ef9b6a6cd52ade19433e737",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754916482,
      "headline": "Are Wall Street Analysts Predicting Abbott Laboratories Stock Will Climb or Sink?",
      "id": 136294306,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=a81dc5b835cf75033823d9fe1c3beea598b4b22f1ef9b6a6cd52ade19433e737"
    }
  }
]